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Abstract
Oxidative stress characterized by an imbalance in the production and degradation  
of radical species has been implicated in the onset and progression of several 
diseases. The efficacy of antioxidants acting via the inhibition of radical chain 
reactions, scavenging of free radicals, direct donation of electrons to radical species 
and chelation of metal ions have been reported to attenuate the oxidative process. 
Vitamin E is an effective antioxidant and its hydrophobic nature and membrane 
permeability offer some benefits to application and bioavailability. This chapter 
highlights the following; structural differences in the vitamin family, biosynthesis 
in plants and the native biological role, antioxidant mechanisms of vitamin E, 
an overview of the prophylactic action of vitamin E as well as the effect on the 
 oxidative process in some diseases.
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1. Introduction
The tocochromanols generally called the vitamin E family are amphipathic 
organic molecules with antioxidant capacity. They are categorized as tocopherols, 
tocotrienols and plastochromanol-8 (PC-8) [1]. All groups have a similar chemical 
structure comprising a polar chromanol head linked with a hydrophobic prenyl 
tail. The positive effect of tocopherols and tocotrienols on reproduction in animals 
called research attention to this family of organic compounds. Vitamin E was first 
described by Evans and Bishop in 1922 [2] as substance ‘X’ [3, 4]. The class of com-
pounds was later called ‘tocopherol’ coined from the Greek words ‘to’kos’ meaning 
‘child birth’, and ‘phe’rein’ meaning ‘to bring forth’. The suffix ‘-ol’ was included due 
to the presence of an alcohol functional group. The tocopherols have a saturated 
prenyl tail while the tocotrienols have unsaturated tails with carbon–carbon double 
bonds at 3′,7′ and 11′ positions. Each group comprises four molecular forms (α, β, γ 
and δ) that are differentiated by the methyl group substitutions in the chromanol 
head group (Figures 1 and 2) which strongly influence their antioxidant activity 
in various systems [3–5]. Plastochromanol-8 (PC-8), is also a natural component 
of plant tissues and was first discovered in the leaves of the rubber tree (Hevea 
brasiliensis), where its concentration exceeded that of α-tocopherol and plastoqui-
none [6]. Structural studies revealed that the compounds were identical to those of 
synthetic PC-8, a γ-tocotrienol homolog but had longer side chains [1].
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The human body tends to accumulate α-tocopherol due to the activity of the liver 
α-tocopherol transfer protein (α-TTP), which enriches plasma with a-tocopherol 
[7]. Besides α-TTP, which resides only in the liver, a system of tocopherol-binding 
proteins (TBPs) cause the localization of tocopherols in various human tissues 
where they are required [8].
The main dietary sources of vitamin E compounds include vegetable oils, nuts 
and seeds. The vitamin E family has been studied extensively due to their diverse 
biological functions and α-tocopherol is reported to have the highest biological 
activity [3]. Although α-tocopherol is universally distributed in the plant kingdom 
and is the predominant vitamin E form in photosynthetic tissues, γ-tocopherol and 
tocotrienols predominate in the seeds of several dicots and monocots [5].
1.1 Biological functions of vitamin E
The most notable biological function of this lipid-soluble is their antioxidant 
capacity. All vitamin E compounds meet the definition of an antioxidant moiety 
with the capacity to inhibit oxidative reactions in vitro [3]. Vitamin E is widely 
accepted as one of the most potent antioxidant in nature and the antioxidant 
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neutralize free radicals (Figure 3). The regeneration mechanism, mostly by vitamin 
C is essential for maintaining viability [9, 10].
The antioxidant capacity of α, β and γ isoforms of both tocopherol and toco-
trienol are similar and the δ isoforms have weaker activity [11, 12]. As the main 
chain-breaking antioxidant in body tissues, the vitamin E isoforms inhibit lipid per-
oxidation especially in polyunsaturated fatty acid component of cell membranes. 
The in vivo antioxidant capacity of vitamin E is not completely clear. The suggested 
in vivo activity is based on the reported in vitro activity [3]. Based on the capacity 
to inhibit oxidation, vitamin E may help ameliorate or suppress the progression of 
oxidative stress related diseases [13].
Other reported biological functions of vitamin E include; regulation of inflam-
matory response, gene expression, cell proliferation, as well as modulation of 
cellular signaling and activity of membrane bound enzymes.
1.2 Biosynthesis of vitamin E
Tocochromanols are only synthesized by photosynthetic organisms. In plants, 
tocochromanol biosynthesis utilizes cytosolic aromatic amino acid pathway for 
head group synthesis while the tail is synthesized by the plastidic deoxyxylulose-
5-phosphate pathway.
The formation of homogentisic acid (HGA) from p-hydroxyphenylpyruvic acid 
(HPP) by p-hydroxyphenylpyruvic acid dioxygenase (HPPD) is the rate-limiting 
step in the synthesis of the head group (Figure 4).
The biosynthesis of tocopherols and the tocotrienols follow the same pathway, 
each class requiring specific substrates and enzymes. HGA is prenylated with either 
phytyl-diphosphate (PDP) or geranylgeranyl diphosphate (GGDP) to yield the 
committed intermediates 2-methyl-6-phytylplastoquinol (MPBQ ) and 2-methyl-
6-geranylgeranylplastoquinol (MGGBQ ) in tocopherol and tocotrienol synthesis 
respectively.
MPBQ methyltransferase (MPBQ MT) transfers a second methyl group to 
MPBQ to form 2,3-dimethyl-5-phytyl-1,4-benzoquinone (DMPBQ ) and to MGGBQ 
to form 2,3-dimethyl-5-geranylgeranyl-1,4-benzoquinone (DMGGBQ ) respc-
tively. Tocopherol cyclase converts MPBQ and DMPBQ to δ- and γ-tocopherols, 
respectively, and the corresponding geranylgeranylated intermediates to δ- and 
γ-tocotrienols. Finally, γ-tocopherol methyltransferase (γ-TMT) adds a methyl 
group to C-6 of the chromanol ring, converting δ- and γ-tocopherols and tocotri-
enols to β- and α-tocopherols and tocotrienols, respectively [14].
Among the vitamin E family present in foods, α-tocopherol is the most impor-
tant to human health [15]. Although all tocopherols are absorbed equally during 
digestion, only α-tocopherol is preferentially retained and distributed through-
out the body [16]. The concentration of γ-tocopherol is far higher than that of 
α-tocopherol in oil seeds though the former is the biosynthetic precursor of the 
Figure 3. 
Reaction of alpha-tocopherol with hydroxyl radical.
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latter. This suggests that the γ-tocopherol methyltansferase reaction is limited. One 
approach to increase α-tocopherol yield in these seeds is to increase the expression 
of γ-tocopherol methyltansferase gene [17].
Figure 4. 
Tocopherol biosynthesis [14]. Abbreviations: PAT, prephenate amino transferase; AdeH, arogenate 
dehydrogenase; TAT, tyrosine amino transferase; HPPD, p-hydroxyphenylpyruvate dioxygenase; HPT, 
homogentisate phytyltransferase; phytyl-DP, phytyl-diphosphate; MPBQ , 2-methyl-6-phytyl-1,4-benzoquinone; 
DMPBQ , 2,3-dimethyl-5-phytyl-1,4-benzoquinone; MT, methyltransferase; SAM, S-adenosyl methionine; TC, 
tocopherol cyclase; MPBQ MT, MPBQ methyltransferase; gamma-TMT, gamma-tocopherol methyltransferase.
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2. Oxidative stress
The reactive oxygen species (ROS) represents the most important class of radical 
species generated in living systems formed from the partial reduction of molecular 
oxygen. Notable members of this family of radicals include superoxide anion (O2
−), 
hydroxyl radical (OH∙), hydrogen peroxide (H2O2), and singlet oxygen (
1O2) which 
are generated by the respiratory chain in mitochondria, enzymatic reactions, 
exposure to UV light, ionizing radiation and heavy metal ions. The mitochondrial 
electron transport chain generates superoxide radicals through the single-electron 
leak at respiratory complexes I and III of the oxidative phosphorylation pathway. 
The flavin-dependent enzymes in the mitochondrial matrix also produce a consid-
erable amount of reactive oxygen species.
The superoxide radical is readily dismutated to hydrogen peroxide. The reactiv-
ity of hydrogen peroxide as a molecule is low but it can penetrate cell membranes 
and generate hydroxyl radical via the Fenton’s reaction [18].





Fe O Fe O
•
+ ++ → +  (1)
The second step is the Fenton reaction:
 2 3
2 2
Fe H O Fe HO HO
+ + − •+ → + +  (2)
Haber and Weiss reaction:
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2 2 2 2
HO H O H O O H
+• •+ → + +  (3)
 –
2 2 2 2
O H O O HO HO
• − •+ → + +  (4)
The chain termination reaction:
 2 3
2
Fe HO H Fe H O
+ • + ++ + → +  (5)
The hydroxyl radical is regarded as the most reactive oxygen radical and can 
cause oxidative damage to cells by attacking biomolecules located a few nanometers 
from the site of generation [19].
Low levels of ROS production are required for important physiological 
functions, including proliferation, host defense, signal transduction, and gene 
expression [20]. There is a cellular balance between ROS generation and clear-
ance in eukaryotic cells. This is achieved by the activity of several antioxidative 
defense mechanisms that comprise enzymes and antioxidants. The five main 
types of primary intracellular antioxidant enzymes are Cu/Zn-superoxide 
dismutase (Cu/Zn-SOD, SOD1) in the cytosol, manganese superoxide dismutase 
(Mn-SOD, SOD2) in the mitochondrial matrix, catalase, glutathione peroxidase 
(GPx), and glutathione reductase (GR). Small molecular weight and non-
enzymatic antioxidants are also involved in the protection of the intracellular 
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components against the reactive oxygen species. However, when cellular pro-
duction of ROS overwhelms these antioxidative mechanisms, oxidative stress 
occurs [18].
The use of the term ‘oxidative stress’ became frequent in the 1970s, but its origin 
dates back to the 1950s when researchers were studying the toxic effects of ion-
izing radiation and free radicals. Oxidative stress refers to a pathological state that 
arises from an imbalance between the production of free radicals and the ability to 
neutralize them by antioxidants. When the antioxidant capacity is reduced, pro-
oxidants can react with surrounding biomolecules and the extent of the reaction is 
dependent on the susceptibility of the biomolecules [20–22].
2.1 Free radical reaction with biomolecules
Biological molecules, notably DNA, proteins and lipids, can be affected by free 
radicals. The reaction of reactive oxygen species (ROS) with these macromolecules 
if not checked generates additional free radicals thereby causing more damage. 
The incorporation of modified bases into a growing DNA molecule has serious 
phenotypic consequences [23]. Mitochondrial DNA is mainly vulnerable, because 
of its closeness to the site of metabolic ROS generation [24]. Telomeres are also 
vulnerable to ROS attack. ROS-accelerated reduction in telomere length hasten cell 
senescence [25].
Oxidation of proteins induce the formation of irreversible disulphide bridges, 
changes in secondary and tertiary structure and ultimately impaired function. The 
degree of the damage depends on the location of the proteins, their composition 
and structure [26]. Some amino acids (tryptophan, tyrosine, histidine and cyste-
ine) are more susceptible to oxidation than others [24].
Damage to lipids is also of great significance because of the negative impact 
on membrane structure and function. The composition of biological membranes 
is very important to the membrane function but also influence susceptibility to 
oxidative damage. Polyunsaturated fatty acids (PUFAs) are much more prone to 
peroxidation than monounsaturated or saturated fatty acid acids. Oxidation of 
lipids can generate a wide range of reactive intermediates which can trigger complex 
chain reactions with widespread effects.
2.1.1 DNA oxidation
Technological advancement in analytical chemistry have provided sensitive 
and specific methods for identifying and quantifying DNA adducts. Application 
of these techniques to the analysis of nuclear DNA from human tissues has made it 
clear that the notion “human genome is pristine if there is no exposure to environ-
mental carcinogens” is incorrect. Much damage is done to DNA molecules endog-
enously by intermediates of oxygen reduction that either attack the nitrogenous 
bases or the deoxyribosyl backbone of DNA (Figure 5) [28].
Hydroxyl radical (HO•) is a provable candidate in DNA oxidation because it is 
extremely reactive. Hydroxyl radicals cannot diffuse beyond two molecular diam-
eters because of their high reactivity [29, 30]. It can add to DNA bases or abstract 
hydrogen atoms to produce DNA adducts in no specific order [28]. The effect on 
nuclear DNA can only be possible if H2O2 generate HO
• on reaction with a metal ion 
in the vicinity of a DNA molecule [31, 32].
Peroxinitrite, a product of the coupling of nitric oxide and superoxide ion (O2−) 
has also been identified as an extremely strong DNA oxidant. Apart from its ability 
to generate HO•, its protonated form (peroxinitrous acid, ONOOH) is an extremely 
reactive oxidant [28].
7
Vitamin E in Human Health and Oxidative Stress Related Diseases
DOI: http://dx.doi.org/10.5772/intechopen.99169
Secondary products of lipid peroxidation reactions are also culpably involved in 
DNA oxidation. Malondialdehyde and 4-hydroxylnonenal can oxidize DNA thereby 
generating several DNA adducts [30].
2.1.1.1 Mechanism of DNA oxidation
When a H-atom is abstracted from C5’ carbon atom in the sugar moiety, the C5′-
centered radical generated binds to the C8-position of the purine base in the same 
nucleoside. The products of this intramolecular cyclization are 8,5’-cyclopurine-2′-
deoxynucleosides (Figure 5). The reactions of carbon-centered sugar radicals result 
in the DNA strand breaks [27].
The reaction of HO• with purines in DNA produces a C-8-hydroxy-adduct radical 
of the purine base which can be converted to the 2,6-diamino-4-hydroxy-5-formami-
dopyrimidine by reduction that ultimately lead to ring opening. The oxidation of 
the C-8-hydroxy-adduct radical of purines yield 8-hydroxypurine HO• can react also 
with the heterocyclic part of the pyrimidine bases to yield several base adducts. For 
example, the reaction of HO• with cytosine and thymine at C5- and C6-positions, 
yields C5–OH and C6–OH adducts respectively. Further oxidation of these adducts by 
water and concomitant deprotonation results in the formation of the respective glycols.
2.1.2 Proteins
The interest in the study of protein oxidation started in the early 1990s with the 
aim to explain oxidative damage to specific purified enzymes or in oxidative stress 
processes involving proteins. The process of protein oxidation by free radicals is an 
important biochemical event in living cells and is implicated in a number of human 
diseases.
Figure 5. 
Oxidation of deoxyribose in purines [27].
Vitamin E in Health and Disease - Interactions, Diseases and Health Aspects
8
2.1.2.1 Oxidation of the protein backbone
The removal of one hydrogen atom from an amino acid residue in a polypep-
tide molecule by a free radical generates a carbon-centered radical. The reaction 
of the carbon-centered radical with O2 forms an alkylperoxyl radical intermedi-
ate which can be converted to an alkylperoxide. The resulting alkoxyl radical 
may be converted to a hydroxyl protein. Steps in this pathway are mediated 
by interactions with HO2
• and are catalyzed by Fe2+. The radical intermediates 
generated can further react with other amino acid residues within the same or 
in different protein molecules thereby generating a new carbon-centered radical 
that can undergo similar reactions. However, when oxygen is absent, two carbon-
centered radicals may react with each other to form a protein–protein cross-link 
(Figure 6) [33].
Peptide bond cleavage occurs by either the diamide or α-amidation pathways. 
ROS attack on glutamyl, aspartyl and prolyl side chains of polypeptide residues 
lead to peptide bond cleavage via a different pathway. Oxalic acid is formed and 
the N-terminal amino acid of the peptide derived from the C-terminal portion 
of the protein will exist as an N-pyruvyl derivative. The involvement of proline 
oxidation is linked to the observation that the number of peptides formed during 
radiolysis of proteins is approximately equal to the number of prolyl residues. It 
was thus proposed that oxidation of prolyl residues would lead to peptide bond 
cleavage. This was verified by Uchida et al. [34] who showed that the oxidation of 
proline residues leads to the formation of 2-pyrrolidone and concomitant peptide 
bond cleavage. The hydrolysis of 2-pyrrolidone by an acid yields 4-aminobutyric 
acid. The observation of 4-aminobutyric acid in protein hydrolysates serve as 
reasonable evidence of the involvement of proline oxidation in peptide bond 
cleavage.
2.1.3 Lipid peroxidation
The adverse effects of lipid peroxidation in biological systems gained attention 
in the 1960’s and it is now known that this reaction is a relevant event in biology and 
medicine [35].
Lipid peroxidation is a chain reaction, catalyzed by transition metals ultimately 
resulting in the breakdown of membrane phospholipids that contain polyun-
saturated fatty acids (PUFAs). The severity of the resulting damage depends on 
the nature and concentration of the oxidant and it may range from reductions 
in membrane fluidity to full disruption of bilayer integrity [30]. The two most 
dominant ROS that can affect lipids profoundly are; hydroxyl radical (•OH) and 
hydroperoxyl radical (HO2•), a protonated form of O2
−. The hydroxyl radical (•OH) 
attack biomolecules located a few nanometers from the site of generation [36]. H2O2 
generated from HO2• can react with redox active metals to generate 
•OH through 
Fenton or Haber-Weiss reactions. The HO2• can also directly initiate the oxidation 
of polyunsaturated phospholipids in cell membrane [37].
Figure 6. 
Formation of carbon-centered radicals during protein oxidation [33].
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2.1.3.1 Lipid peroxidation process
Lipid peroxidation reactions involve the abstraction of hydrogen from a carbon 
in a lipid molecule followed by the insertion of oxygen to form lipid peroxyl radicals 
and hydroperoxides. Glycolipids, phospholipids, and cholesterol are susceptible to 
these damaging and possibly lethal peroxidative alterations. The enzymes; lipoxy-
genase, cyclooxygenase and cytochrome P450 can also oxidize lipids.
Lipid peroxidation reactions are categorized into three phases: initiation, propa-
gation, and termination. In the initiation step, pro-oxidants like hydroxyl radical 
removes an allylic hydrogen forming a carbon-centered lipid radical (L•). During 
the propagation phase, the lipid radical (L•) rapidly reacts with oxygen to form a 
lipid peroxyl radical (LOO•). The LOO• can react with neighboring lipid molecules 
form a new L• and lipid hydroperoxide (LOOH) (Figure 7).
The reaction process can be terminated by antioxidants that donate hydrogen 
atom(s) to the lipid peroxyl radical species resulting in the formation of non-radical 
products. For example, vitamin E donate hydrogen atom to the LOO• species. The 
resulting ‘oxidized’ vitamin E radical reacts with another LOO• forming non-radical 
products. The chain reaction continues in the absence of antioxidants [38].
2.1.3.2 Lipid peroxidation products
Lipid peroxidation produces a number of oxidation products categorized as 
primary and secondary products. Lipid hydroperoxides (LOOH) are the main 
primary products of lipid peroxidation. Several aldehydes are formed as secondary 
products from the hydroperoxides including; malondialdehyde (MDA), propanal, 
hexanal, and 4-hydroxynonenal (4-HNE) [39, 40]. 4-HNE and MDA have been 
reported to be the most toxic and most mutagenic product of lipid peroxidation 
respectively [41].
The decomposition of arachidonic acid (AA) and larger PUFAs as well as 
enzymatic processes during the biosynthesis of thromboxane A2 (TXA2) and 
12-l-hydroxy-5,8,10-heptadecatrienoic acid (HHT), or the non-enzymatic processes 
Figure 7. 
Lipid peroxidation process [30].
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by bicyclic endoperoxides produced during lipid peroxidation, can generate MDA in 
vivo. MDA generated by these processes can be enzymatically metabolized or form 
adducts with biomolecules [30].
2.2 Oxidative stress and human diseases
Oxidative stress has been implicated in the onset and progression of pathological 
conditions such as cancer, cardiovascular disease, neurological disorders, diabetes 
as well as aging [42–44]. The negative impact of oxidative stress is due to the dam-
aging consequences of free radicals on important biological molecules [45]. Free 
radical mediated oxidative stress increases with age and may overwhelm natural 
repair systems [46]. A review of the mechanism of human diseases resulting from 
oxidative stress was published by Rahman [47]. The influence of oxidative stress 
on aging is now established and the associated diseases include; cardiovascular 
diseases, Huntington’s disease, Alzheimer’s disease, stroke, Parkinson’s disease and 
cancer [47, 48].
The use of oxidative stress biomarkers for the diagnosis of acute and chronic 
diseases indicate the involvement of oxidative stress in such pathological condi-
tions. This is confirmed by the difference in the concentration of these biomarkers 
in healthy and ill subjects evaluated for long periods. Representative biomarkers of 
oxidative damage associated with some human diseases were summarized by Valko 
et al. [20] and are presented in Table 1.
3. Roles of vitamin E in human health and disease
Natural antioxidants including vitamin E have gained relevance in combating 
oxidative stress [49]. The vitamin E required by humans is solely acquired from 
diet. The lipohilic nature of vitamin E support the theory of high antioxidant 
capacity in cell membranes [47]. The capacity to be replenished by other antioxi-
dants such as ascorbic acid is another important factor [9, 10]. Vitamin E has been 
reported to slow down the progression of oxidative assaults on biomolecules thus 
suppressing diseases [13]. The remaining sections of this chapter shall focus on the 
roles of vitamin E in the management of some illnesses and human wellbeing.
Oxidation products used as biomarkers for oxidative stress Disease
MDA, GSH/GSSG ratio, NO2-Tyr, 8-OH-dG Cancer
HNE, GSH/GSSG ratio, acrolein, NO2-Tyr, F2-isoprostanes Cardiovascular disease
F2-isoprostanes, GSH/GSSG ratio Rheumatoid arthritis
MDA, HNE, GSH/GSSG ratio, F2-isoprostanes, NO2-Tyr, AGE Alzheimer’s disease
HNE, GSH/GSSG ratio, carbonylated proteins, Fe-level Parkinson’s disease
F2-isoprostanes, GSH/GSSG ratio Ischemia and reperfusion
MDA, HNE, Acrolein, NO2-Tyr, F2-isoprostanes Atherosclerosis
MDA, GSH/GSSG ratio, F2-isoprostanes, NO2-Tyr, AGE, S-gluathionylated 
proteins
Diabetes mellitus
Abbreviations: MDA, malondialdehyde; HNE, 4-hydroxy-2-nonenal; AGE, advanced glycation end products; 
8-OH-dG, 8-hydroxy-20-deoxyguanosine; GSH, reduced glutathione; GSSG, oxidized glutathione; NO2-Tyr, 
3-nitro-tyrosine.
Table 1. 
Oxidative stress biomarkers associated with some human diseases [20].
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3.1 Vitamin E in disease prophylaxis
Epidemiological studies and observational surveys link populations that consume 
a high amount of vitamin E to a reduced incidence of chronic diseases. This disease 
preventing capacity is largely linked to the antioxidant capacity of the vitamin E 
family. The antioxidant property is based on the capacity of vitamin E to donate 
hydrogen to free radicals and its lipid membrane solubility. The resulting tocopher-
oxyl radical is far less reactive compared to free radicals so does not propagate the 
oxidative chain reaction. The tocopheroxyl radical can be reduced by ascorbic acid or 
react with another tocopheroxyl radical to form stable products [50].
Vitamin E is an immune booster which may play an essential role in the observed 
prophylactic action. The vitamin E family have been reported to regulate cell 
growth and induce apoptosis in tumor cells. Several other anticarcinogenic mecha-
nisms have been reported for the vitamin E family including the stimulation of the 
migration of macrophages and lymphocytes that contain tumor necrosis factor to 
tumor sites [51] and modulation of the expression of oncogenes. Additional studies 
have revealed that vitamin E succinate, a modified product can specifically induce 
apoptosis in tumor and cancer cells but not normal epithelial cells in mammary and 
prostatic glands [50, 52].
The hypothesis that atherosclerosis may be prevented by blocking the oxida-
tive modification of LDL cholesterol, a key process in the onset and progression of 
atherosclerosis renewed interest in vitamin E. Research outcomes have documented 
beneficial effects of vitamin E on several stages of the atherosclerotic process [53].
3.2 The role of vitamin E in cardiovascular disease
The development of atherosclerosis depends on the pro- and anti-inflammatory 
as well as pro- and anti-oxidant balance [54]. The oxidation of LDL is a principal 
component of atherosclerosis and is implicated in the onset of cardiovascular 
diseases via several mechanisms. At low concentrations, oxidized LDL can stimu-
late the production of inflammatory markers such as cell adhesion molecules and 
macrophage colony stimulating factor by endothelial cells. The resulting endothelial 
dysfunction can result in either cell growth or apoptotic cell death that can cause 
vasoconstriction.
At high concentrations, oxidized LDL are recognized by scavenger receptors and 
they are phagocytosed by macrophages resulting in the formation of lipid-laden 
foam cells. The cytotoxic property of oxidized LDL in cultured endothelial cells, 
the ability to inhibit macrophage motility and the inhibitory effect on nitric oxide-
induced vasodilation are other potential atherogenic possibilities. Experimental 
evidence also back the involvement of free radicals in congestive heart failure 
(CHF), vascular injury and organ dysfunction [55, 56].
The vitamin E family has received considerable attention in atherosclerosis 
research based on the capacity to inhibit LDL oxidation and decrease uptake of 
oxidized LDL by macrophages in human arterial lesions. The vitamin E compounds 
are reported to be favorable modulators of the atherogenic process at the molecular 
and cellular levels [57, 58]. Other potential mechanisms of action include; reduction 
of endothelial injury, reduction in the expression of adhesion molecules, reduction 
in endothelial cell adhesion, inhibition of inflammatory cytokines and chemokines 
synthesis, inhibition of smooth muscle cell proliferation, inhibition of platelet 
aggregation, increased NO production and arterial dilation.
An in vitro study on the effect of vitamin E on LDL oxidation in the blood 
plasma of healthy volunteers revealed that enrichment with vitamin E increased 
resistance to LDL-oxidation in a dose-dependent manner [59] and decreased uptake 
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of oxidized LDL by macrophages in human arterial lesions. In another study, 
vitamin E enrichment increased LDL vitamin E concentration by approximately 2.5 
folds and the susceptibility to oxidation was reduced by 30–40% [60].
The results obtained from in vitro studies have not been replicated exactly in 
clinical trials.
3.3 The role of vitamin E in cancer
Cancer is a complicated disease condition characterized by the inability to 
control cell growth. Carcinogenesis has been categorized into three stages; initia-
tion, promotion, progression and the action of free radicals have been implicated in 
all stages due to their capacity to react with all components of DNA. The concentra-
tion of oxidized DNA adducts is directly linked to the size of benign tumors and can 
directly affect the transformation to malignancy [47].
The vitamin E compounds are powerful antioxidants thus can inhibit DNA 
oxidation. The natural forms of vitamin E have been reported as effective agents 
for cancer therapy [61]. The result of the selenium and vitamin E cancer prevention 
trial (SELECT) revealed that dietary supplementation of α-tocopherol at 400 IU/d 
increased the risk of prostate cancer [62]. The anticancer properties of α-tocopherol 
have been studied the most among the vitamin E compounds and available results 
reveal that the anticancer property of the compound is not very promising.
However, the vitamin E forms; γ-tocopherol, δ-tocopherol, γ-tocotrienol and 
δ-tocotrienol have been reported to have higher anticancer property compared to 
α-tocopherol. These vitamin E forms are able to inhibit multiple cancer promot-
ing pathways by inhibiting the formation of eicosanoids. In conjunction with 
their metabolic product; 13′-carboxycromanol, they inhibit the cyclooxygenases 
(COX-1 and -2) and 5-lipoxgenase (5-LOX). Gamma- and δ-tocotrienols also 
suppress the activation of nuclear factor kappa B (NF-kB) and signal transducer 
and activator of transcription factor 3 (STAT3). These activities neutralize 
pro-inflammatory tumor microenvironments that favor cancer development, 
invasiveness, and resistance to treatment. These vitamin E compounds also target 
cancer cells and cancer stem cells by promoting apoptosis, antiangiogenesis, and 
antiproliferation partially via modulating epigenetic events and other signaling 
pathways. The modulatory effect of tocotrienols on immunity may also contribute 
to cancer prevention [61].
The anti-inflammatory mechanism of vitamin E compounds and their 
metabolites is based on their capacity to inhibit the cycloxogenases and the 
lipoxygenase involved in eicosanoid synthesis. Reduced synthesis of prostaglan-
dins and leukotrienes have been reported to slow down tumorigenesis, angiogen-
esis and metastasis. The activity of COX-2 and 5-LOX as well as the concentration 
of Prostaglandin E2 (PGE2) are increased in tumor cells. These events promote 
angiogenesis and resistance to apoptosis via PGE2 receptor-mediated signaling in 
cancer cells [61, 63, 64].
The non-steroidal anti-inflammatory drugs (NSAIDs) that inhibit inflammation 
via the inhibition of COX and 5-LOX have been shown to inhibit tumor develop-
ment in various cancer models [65, 66]. Studies have revealed that γ-tocopherol, 
δ-tocopherol and γ-tocotrienol as well as their metabolites can inhibit COX- and 
5-LOX at physiological concentrations [61].
Pro-inflammatory cytokines secreted by macrophages associated with tumor 
and cancer cells also promote tumor growth and invasiveness. The cytokines (inter-
leukin-1 (IL-1), interleukin-6 (IL-6)) and tumor necrosis factor alpha (TNF-α), acti-
vate NF-kB and STAT3 in cancer cells. The activation of NF-kB and STAT3 increase 
the expression of genes that promote cell survival, proliferation, angiogenesis and 
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invasiveness [67]. The inhibition of NF-kB and STAT3 as well as their regulatory 
cytokines is a potent target to suppress tumor development and progression.
Vitamin E compounds have been shown to block NF-kB and STAT3 activation 
and their regulated genes in macrophages and cancer cells [68]. The inability to 
express survival genes following the inhibition of NF-kB and STAT3 sensitizes the 
cancer cells to therapeutic drugs. γ- and δ-Tocotrienols have been reported to be 
active inhibitors of NF-kB and STAT3 [69].
The immune system play an important role in the defense against cancer 
by detecting and killing tumor cells [68]. A combination of tocotrienols as 
supplements have been reported to modulate immune response and has a higher 
anticancer activity than α-tocopherol alone [70]. Tocotrienol supplementation 
enhanced lymphocyte proliferation without affecting major cytokines in old 
mice but not young ones, suggesting an age-dependent immune modulatory 
function [71]. The supplementation with the vitamin E compounds increase 
interferon gamma (IFN-γ) and interleukin 4 (IL-4), thus enhancing antibody 
production while suppressing TNF-α in stimulated splenocytes. This activity 
observed in response to tetanus toxoid vaccination suggest anticancer activity via 
immune modulation [68].
The vitamin E forms have been reported to directly target cancer cells. 
γ-Tocopherol, δ-tocopherol, γ-totrienol, δ-tocotrienol and 13′-carboxychroma-
nol have been reported to induce the arrest of cancer cell growth, apoptosis and 
autophagy in several types of cancer cells [72]. The preferential accumulation 
of γ-totrienol, δ-tocotrienol and 13′-carboxychromanol in cancer cells may be 
responsible for the observed higher anticancer activity compared to the tocopherol 
counterparts [73].
The capacity of these vitamin E forms to induce pathways associated with 
antiproliferation [74], elevation of mitochondria apoptotic proteins [73], autophagy 
marker LC3II and endoplasmic reticulum stress markers such as c-Jun N-Terminal 
kinase (JNK) phosphorylation and death receptor-5 (DR5) pro-apoptotic pathway 
[75] may contribute to the reported anticancer activity. The anticancer activity has 
also been linked with the capacity of the vitamin E forms and 13′-carboxylchroma-
nol to modulate sphingolipid metabolism. At elevated concentrations, sphingolipids 
such as dihydroceramide, dihydroshpingosine and ceramides induce stress and 
apoptosis as well as inhibit cell growth [76]. This has been shown in prostate, colon, 
pancreatic and breast cancer cells were an elevation of the sphingolipids precede 
or happen simultaneously with cell death [74]. Suppressing de novo synthesis of 
sphingolipids reverses the anticancer activity of the vitamin E forms. Research 
is still ongoing to completely unravel the interactions and effect of sphingolipid 
modulation in vivo [61].
3.4 The role of vitamin E in cataracts
Cataracts are one of the commonest reasons for critical vision distress in adult 
humans. They essentially happen because of the aggregation of proteins oxidized 
by free radicals. A few observational examinations have uncovered a likely con-
nection between vitamin E supplements and the danger of cataracts development. 
Leske et al. [77] reported that lens clarity was higher in individuals receiving 
vitamin E supplements and those with higher plasma concentrations of the vitamin. 
In another investigation, vitamin E supplementation was related with reduced 
opacification of the lens. However, in a randomized Age-Related Eye Illness Study 
(AREDS), vitamin E had no clear impact [78]. Like in other disease conditions, the 
exact mechanism of the observed positive effects of vitamin in the reduction of 
cataract formation in vivo is in progress [79].
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3.5 Roles of vitamin E in other diseases
The role of vitamin E gas been studied in several other diseases conditions linked 
to oxidative stress. For example, stroke has been linked with free radical reactions 
arising from xanthine oxidase, cyclooxygenase and inflammation [80]. These free 
radical reactions can cause neuronal death [81]. The oxidative assault is increased 
by the biochemical processes associated with stroke.
Oxidative stress is also implicated in the onset and progression of the neuro-
logical disorders; Alzheimer’s disease and Parkinson’s disease. In both conditions, 
logarithmic age-dependent increase in the oxidation of proteins, lipids and DNA as 
well as decreased in vivo antioxidant activity has been reported [47]. In Alzheimer’s 
disease, oxidation induce protein cross linking and aggregation of β-amyloid pro-
tein which in turn induce the oxidation of carbohydrate side chains of membrane 
lipids leading to neuronal membrane breakdown [82]. Oxidation of lipids also 
accompany the process and has been quantitatively assessed by increased concen-
tration of 4-hydroxyl-2-nonenal-glutathione conjugates in the brain [83].
In diabetes, free radical-induced OS has been reported to play a significant role 
in the development of insulin resistance, β-cell dysfunction and impaired glucose 
tolerance. Hyperglycemia worsens the oxidative burden following the formation of 
advanced glycation end products (AGEs).
The biochemical importance of oxidative stress in the onset and progression 
of disease conditions underscores the relevance of vitamin E in prevention and 
management.
In HIV infection, it is not exactly clear if vitamin E supplementation has the 
same effect at all stages of the disease. However, high serum concentration of 
vitamins A and E have been reported to affect disease progression. Vitamin E con-
centrations higher than 23.5 μM reduced the risk of progression of HIV-1. Vitamin 
E has also been shown to normalize immune system parameters in murine acquired 
immunodeficiency syndrome as well as protect against bone marrow toxicity of 
azidothymidine. Protection against azidothymidine toxicity was confirmed in stage 
IV HIV patients on alpha-tocopherol supplementation. High doses have also been 
reported to restore delayed skin hypersensitivity, stimulate interleukin-2 produc-
tion and T-helper (CD4 T-cell) proliferation [79].
4. Discussion
The in vitro antioxidant activity of vitamin E compounds are well documented. 
However in vivo studies on prevention and treatment of oxidative stress-related dis-
eases have been disappointing. Till date, there is no approval for the clinical use of 
vitamin E as a drug even though vitamin E consumption has been reported to boost 
immunity, improve skin health and vision. Vitamin E remains a popular supplement 
and is generally regarded as safe by the FDA.
Vitamin E is the main lipid soluble antioxidant [79] in the cell membrane thus 
will always attract research attention considering the relevance of membrane lipid 
oxidation [84]. The bioactivity of vitamin E in the cell membrane may be a direct 
approach to limit oxidation of other biomolecules that can form conjugates with 
oxidized lipids.
Emerging research outputs are shedding light on the disparity between in vitro 
and in vivo antioxidant capacity of vitamin E [85]. In macrophages, the oxidation of 
lipids occur in the lysosomes. Alboaklah and Leake [85] conducted an experiment 
on LDL oxidation at lysosomal pH (about 4.5). In their experiment, LDL enriched 
with vitamin E was oxidized by Cu2+ more slowly compared to control LDL. At 
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pH 4.5, the enriched LDL was not protected against oxidation by low concentrations 
of Cu2+ or Fe3+. They observed that the enriched LDL reduced the Cu2+ and Fe3+ to 
the more pro-oxidant Cu+ and Fe2+ at a faster rate than control LDL at lysosomal 
pH. This may partly be responsible for the observed reduction in the bioactivity of 
vitamin E compounds in vivo.
The bioavailability of vitamin E has been another complication in clinical appli-
cations. Recent data indicate that the absorption of vitamin E is far more complex 
than previously thought. Details about the digestion, absorption and transport of 
vitamin E are presented in a review by Reboul [86]. The author concluded that the 
process is only partly understood and suggested further studies to decipher the 
molecular mechanisms [86].
The poor water solubility of vitamin E has been implicated in the low oral 
bioavailability [87]. Recently, nanoformulations such as nanovesicles, solid-lipid 
nanoparticles, nanostructured lipid carriers, nanoemulsions, and polymeric 
nanoparticles have shown promising outcomes in improving the efficacy and 
bioavailability of vitamin E.
Lipid-based nanovesicles such as niosomes and liposomes are highly promising 
for the delivery of lipophilic drugs and active compounds. Although niosomes and 
liposomes have similar physicochemical properties, niosomes have a higher permea-
bility to small solutes and ions than liposomes. The application of these nanovesicles 
as drug delivery vehicles is suitable because they are non-toxic and stable.
In a study to enhance the tumor-suppressing effect of tocotrienols in vivo, Fu 
et al. [88] first developed a D-α-tocopheryl polyethylene glycol 1000 succinate 
(TPGS)-based noisome [88, 89]. This system appeared to significantly increase 
tocotrienol uptake in vitro using A431, B16F10 and T98G cell lines and hence 
improved the therapeutic efficacy. TPGS can be functionalized as an excellent 
solubilizer, emulsifier, permeation and bioavailability enhancer for hydrophobic 
drugs [90]. TPGS has demonstrated capacity to selectively induce apoptogenic 
activity against many cancer types by targeting the activation of mitochondrial 
mediators of apoptosis [91]. Another 6-O-palmitoyl-ascorbic acid (PA) based 
niosomes (comprising AP, TPGS, cholesterol, and 1,2-distearoyl-sn-glycero-
3-phosphoethanolamine-N-[carboxy(polyethylene glycol)-2000] (DSPE-PEG 
(2000)-carboxylic acid)) was developed by Tan et al. [92] targeting transferrin 
receptors for intravenous administration of γ-tocotrienol aimed at treating breast 
cancer. Both in vitro and in vivo studies have proven that tumor-targeted niosomes 
significantly improve the therapeutic efficacy of γ-tocotrienol. These studies sug-
gests that nanovesicles can be suitable carriers for improved delivery and enhanced 
efficacy of vitamin E [93].
5. Conclusion
Although the antioxidant and antiproliferative properties of vitamin E against 
oxidative stress related diseases have been reported, there is currently no approval 
for clinical application. A modified product, TPGS has been approved by the FDA 
as a safe pharmaceutical adjuvant with high biocompatibility. Despite the reported 
bioactivity of the tocotrienols, studies so far are inconclusive. The reported in vitro 
biochemical properties of the vitamin E family will continually call the attention 
of researchers since they are natural and can play essential roles in ameliorating the 
impact of oxidative assault in biological membranes. To maximize the prophylactic 
and curative properties of vitamin E, further research on absorption, cellular 
uptake, solubility, and stability is required to improve bioavailabilty and efficacy 
in vivo.
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